Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer
Lists
Only you see this
Abstract
CEA and CA 15.3 are useful prognostic factors in NP and NN breast cancer patients. CEA >7.5 microg/L is associated with a high probability of subclinical metastases.
BibTeX
@inproceedings{molina2010prospective,
author = {Rafael Molina and José Maria Augé and B. Farrús and Gabriel Zanón and Jaume Pahisa and Montserrat Muñoz-Mateu and Aureli Torné and Xavier Filella and José Miguel Escudero Fernández and P. Fernandez and Martín Velasco},
title = {{Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer}},
booktitle = {Clinical},
year = {2010},
doi = {10.1373/clinchem.2009.135566},
}Loading related content...